Peptide record

TPDB26718

Antibacterial Toxicity modified_plain modified
6 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB26718
Antibacterial Toxicity
Anti-infective peptides Toxicity and safety peptides
Peptipedia
modified_plain
Yes
A 6-aa modified multi-activity (Antibacterial and Toxicity) peptide sequence curated from Peptipedia, with an available 3D structural model.
Modified, details unspecified
Sequence
WRWXRR
Physicochemical Analysis
C40H58N16O6
ANDCEQGHILKMFPSTYV
R
859.00
12.70
3
0
2
+3
-1.27
-2.550
0.00
Mammalian: 2.8 hour Yeast: 3 min E.coli: 2 min
11000
1280.55
0
Residue Composition
number
0
A
3
R
0
N
0
D
0
C
0
E
0
Q
0
G
0
H
0
I
0
L
0
K
0
M
0
F
0
P
0
S
0
T
2
W
0
Y
0
V
Amino Acid Distribution
A: 0 R: 3 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 0 H: 0 I: 0 L: 0 K: 0 M: 0 F: 0 P: 0 S: 0 T: 0 W: 2 Y: 0 V: 0
Chemical Descriptors
6
C40H58N16O6
859.00
12.70
+3
-1.27
-2.550
Evidence Records 2 records
Evidence 1 Activity

Activity

10% Hemolysis
Toxicity
140 µg/mL
Hemolytic Cytotoxic
10% Hemolysis | 140 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Antibacterial evaluation of structurally amphipathic, membrane active small cationic peptidomimetics: synthesized by incorporating 3-amino benzoic acid as peptidomimetic element. | Eur J Med Chem | 2014
Evidence 2 Activity

Activity

50% Hemolysis
Toxicity
370 µg/mL
Hemolytic Cytotoxic
50% Hemolysis | 370 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Antibacterial evaluation of structurally amphipathic, membrane active small cationic peptidomimetics: synthesized by incorporating 3-amino benzoic acid as peptidomimetic element. | Eur J Med Chem | 2014